Skip to main content
. Author manuscript; available in PMC: 2024 Jun 1.
Published in final edited form as: J Orthop Res. 2022 Nov 6;41(6):1299–1309. doi: 10.1002/jor.25472

Table 2.

Demographic and clinical information for the full cohort and organized by IPFP scarring severity

Full Cohort
N (% female) 28 (64%)
Age (years) 66 ± 7
Revision prior to imaging, N (%) 5 (18%)
Revision after imaging, N (%) 12 (43%)
Length of Implantation (years) 4.9 ± 3.5
Osteolysis, N (%) 6 (21)
Synovitis, N (%) 10 (36)
Joint effusion, N (%) 4 (14)
Marrow edema, N (%) 3 (11)
Fibrous membrane formation, N (%) 3 (11)

Distribution of Outcomes by IPFP scarring severity
Variable None Mild Moderate Severe
N (% Female) 3 (67) 14 (79) 4 (50) 7 (43)
Age (years) 65 ± 8 67 ± 6 66 ± 8 67 ± 8
Revision prior to imaging, N (%) 1 (33) 2 (14) 1 (25) 1 (14)
Revision after imaging, N (%) 2 (67) 6 (43) 2 (50) 2 (29)
Length of Implantation (years) 7.6 ± 1.0 4.2 ± 3.0 6.4 ± 1.0 4.4 ± 4.0
Osteolysis, N (%) 2 (67) 2 (14) 0 (0) 2 (29)
Synovitis, N (%) 2 (67) 5 (36) 1 (25) 2 (29)
Joint effusion, N (%) 0 (0) 2 (14) 0 (0) 2 (29)
Marrow edema, N (%) 0 (0) 1 (7) 1 (25) 1 (14)
Fibrous membrane formation, N (%) 0 (0) 2 (14) 0 (0) 1 (14)

Age and Length of Implantation expressed as mean ± SD